Mayence Print Management (MPM) has renewed its contract with GlaxoSmithKline (GSK) to produce the pharmaceutical company's printed products for another three years.
The £15 million contract was agreed following MPM's three-month review and tender exercise with GSK.
MPM - which operates 11 sites across Europe, of which three are in the UK - said it won the contract as its prices proved to be 25% lower than bids from 10 other print management companies in the country.
The deal will see MPM producing over 3,000 individual printed products annually.
Darren Kopitko, managing director of the print management business, said: "GSK's decision to re-appoint Mayence UK for a further three years is a testimony to the dedication, hard work and the very high standards of customer care my on-site team has delivered over the previous five years."
GSK said it was looking for a company with excellent industry knowledge and good personal customer service, which would meet the needs of its pharmaceutical, nutritional and consumer healthcare segments.
Copyright © Press Association 2010



